Filing Details
- Accession Number:
- 0002001011-25-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-11 18:17:22
- Reporting Period:
- 2025-07-10
- Filing Date:
- 2025-07-11
- Accepted Time:
- 2025-07-11 18:17:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1223000 | W John Kozarich | 555 Heritage Drive Suite 200 Jupiter FL 33458 | Yes | No | No | No |
Transaction Summary
Sold: | 934 shares | Avg. Price: $125.00 | Total Value: $116,750.00 |
Number of Shares After Transactions: | 46,456 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-07-10 | 934 | $125.00 | 46,456 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.